schizophrenia

News and resources

Oct 09 2024

Schizophrenia-related hallucinations linked to disrupted motor-sensory signals – News-Medical.Net

by Clinical Editor

No Comments

Schizophrenia-related hallucinations linked to disrupted motor-sensory signals News-Medical.Net

Oct 09 2024

Scientists Say They’ve Traced Back the Voices Heard by People With Schizophrenia – Futurism

by Clinical Editor

No Comments

Scientists Say They’ve Traced Back the Voices Heard by People With Schizophrenia Futurism

Oct 08 2024

Police in Detroit seek missing 34-year-old man with schizophrenia – WDIV ClickOnDetroit

by Clinical Editor

No Comments

Police in Detroit seek missing 34-year-old man with schizophrenia WDIV ClickOnDetroit

Oct 08 2024

Old Drug Repurposed for Schizophrenia Could Reap Alzheimer’s Windfall

by Clinical Editor

No Comments

Bristol-Myers’ newly approved schizophrenia treatment might be coming full circle.

Oct 07 2024

Yale doctors weigh in on the first FDA-approved schizophrenia drug in nearly 30 years

by Clinical Editor

No Comments

For the first time in nearly 30 years, the U.S. Food and Drug Administration has approved a new drug treating schizophrenia, offering hope for patients who have struggled with the...

Oct 07 2024

The quiet weight of schizophrenia: Confronting it head on

by Clinical Editor

No Comments

The friend who bears the emotional weight of watching someone they love slip into their condition. These individuals are the unsung pillars of a society that lacks the infrastructure to...

Oct 06 2024

US approves schizophrenia drug with new mode of action – Chemistry World

by Clinical Editor

No Comments

US approves schizophrenia drug with new mode of action Chemistry World

Oct 06 2024

Abbvie’s Emraclidine: M4 Agonist Might Become Best-In-Class In Schizophrenia (NYSE:ABBV) – Seeking Alpha

by Clinical Editor

No Comments

Abbvie’s Emraclidine: M4 Agonist Might Become Best-In-Class In Schizophrenia (NYSE:ABBV) Seeking Alpha

Oct 05 2024

Revolutionary drug for schizophrenia wins US approval – Nature.com

by Clinical Editor

No Comments

Revolutionary drug for schizophrenia wins US approval Nature.com

Oct 05 2024

What happens in the brain when a person with schizophrenia ‘hears voices’?

by Clinical Editor

No Comments

Auditory hallucinations are likely the result of abnormalities in two brain processes: a ‘broken’ corollary discharge that fails to suppress self-generated sounds, and a ‘noisy’ efference copy that makes the...